[1] Kanda T, Goto T, Hirotsu Y, et al. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review[J]. Int J Mol Sci,2019,20(6):1358. [2] Sun Y, Wu X, Zhou J, et al. Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy[J]. Clin Gastroenterol Hepatol,2020,18(11):2582-2591. [3] Wang K, Lu X, Zhou H, et al. Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study[J]. Gut,2019,68(4):729-741. [4] 司薇, 徐丹. 肝癌与肝硬化患者血清叶酸水平对比[J]. 中国老年学杂志,2021,41(16):3412-3414. [5] 于欣, 林涛, 何廉旗. HBV相关肝病患者血清同型半胱氨酸、叶酸、维生素B12、铁蛋白水平变化及临床应用价值[J]. 检验医学与临床,2021,18(16):2318-2320. [6] 郭瑶尝, 江昌铭, 舒文琳. 重组人生长激素与人血白蛋白治疗肝硬化低蛋白血症疗效的Meta分析[J]. 中国基层医药,2020,27(23):2825-2829. [7] 中华医学会感染病学分会,中华医学会肝病学分会. 慢性乙型肝炎防治指南 (2019 年版)[J]. 实用肝脏病杂志,2020,23(1):9-32. [8] 林国桢, 代天星, 刘荣强, 等. 不同肝功能Child-Pugh分级对肝癌肝移植受者预后的影响[J]. 器官移植,2019,10(3):308-312. [9] Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis[J]. Clin Gastroenterol Hepatol,2020,18(12):2650-2666. [10] Treem WR, Palmer M, Lonjon-Domanec I, et al. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis[J]. Drug Saf,2021,44(2):133-165. [11] Guan X, Xing F, Li Y. Alcohol consumption increases the incidence of hepatocellular carcinoma in patients with hepatitis B cirrhosis but not in patients with hepatitis C cirrhosis[J]. Eur J Gastroenterol Hepatol,2021,33(9):1218-1221. [12] Li L, Huang Q, Yang L, et al. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004[J]. Nutrients,2022,14(6):1224. [13] 王洪涛, 王捷, 区庆嘉, 等. 生长激素受体mRNA在肝细胞癌和癌旁肝硬化组织中的表达[J]. 癌症,2002,21(2):146-148. [14] Karabulut D, Ozturk E, Kuloglu N, et al. Effects of vitamin B12 on methotrexate hepatotoxicity: evaluation of receptor-interacting protein (RIP) kinase[J]. Naunyn Schmiedebergs Arch Pharmacol,2020,393(12):2473-2480. [15] 姜思雨, 林秋燕, 艾英杰, 等. 血清维生素 B12 水平预测肝硬化食管胃静脉曲张患者再出血的诊断价值[J]. 中国医师杂志,2021,23(3):343-346. [16] 闫登科, 李美娇, 黄瑞娜. 维生素D3对乙型肝炎肝硬化代偿期患者肝功能、肝纤维化指标及免疫因子的影响[J]. 中西医结合肝病杂志,2021,31(7):613-615. [17] Ho HL, Tsai MH, Hsieh YH, et al. Folic acid ameliorates homocysteine-induced angiogenesis and portosystemic collaterals in cirrhotic rats[J]. Ann Hepatol,2019,18(4):633-639. [18] 姚小健, 黄红霞, 陈勇. 乙型肝炎肝硬化患者血清血小板衍生生长因子和叶酸水平变化[J]. 实用肝脏病杂志,2018,21(1):76-79. [19] 予诗, 夏仁兴, 陈俊西, 等. 肝苏颗粒联合恩替卡韦对乙型肝炎肝硬化患者血清生长激素、免疫功能及临床证候影响[J]. 中西医结合肝病杂志,2020,30(3):211-214. |